-

Komodo Health Appoints Paul Thomas SVP of Finance and Acting CFO

SAN FRANCISCO--(BUSINESS WIRE)--Komodo Health, the Evidentiary Standard for real-world data and healthcare analytics, today announced the appointment of Paul Thomas as Senior Vice President of Finance and Acting Chief Financial Officer. In this role, Thomas will oversee all aspects of Komodo Health's financial operations and strategy while serving on the company's executive leadership team.

"Paul's ability to drive operational excellence while focusing on long-term value creation makes him the ideal leader to strengthen our financial foundation as we pursue our mission of reducing the burden of disease." Arif Nathoo, MD, CEO and Co-Founder

Share

Thomas brings over 20 years of private and public corporate finance and investment research experience to Komodo Health. Since joining Komodo Health last year, Thomas has significantly strengthened the company's financial infrastructure and strategic capabilities, positioning the organization for continued growth and operational excellence in the evolving healthcare technology landscape.

"Paul's financial acumen and strategic leadership have already made a significant impact on Komodo's growth trajectory," said Arif Nathoo, MD, CEO and Co-Founder of Komodo Health. "His ability to drive operational excellence while focusing on long-term value creation makes him the ideal leader to strengthen our financial foundation as we pursue our mission of reducing the burden of disease."

Prior to joining Komodo Health, Thomas led Strategic Finance and Investor Relations at Talkdesk and played a key role in taking Sumo Logic public in September 2020. He began his career as a semiconductor engineer working at leading manufacturers including Intel Corporation, and later moved into finance, working at Merrill Lynch, Bank of America, and Goldman Sachs.

"At Komodo, we strive to empower healthcare and Life Sciences organizations with comprehensive, patient-centric data insights and an AI-powered platform that delivers immediate value so they can improve patient outcomes," said Thomas. "Strong financial strategy is critical to our execution, and I'm excited to build on the momentum we've established and help drive Komodo's next phase of growth."

About Komodo Health

Komodo is a healthcare insights and technology company that delivers the Evidentiary Standard for real-world data and analytics. By pairing the industry’s most complete, unbiased view of patient encounters with AI-enabled and fit-for-purpose software, Komodo connects the dots between patient journeys and large-scale health outcomes. Across Life Sciences, payers, providers, and developers, Komodo delivers a velocity advantage by helping its customers accurately and efficiently access patient-centric insights at scale to drive faster decision-making, optimize workflows, close gaps in care, and help reduce the burden of disease. For more information, visit Komodohealth.com.

Contacts

Rowena Kelley
858.255.1651
media@komodohealth.com

Komodo Health


Release Versions

Contacts

Rowena Kelley
858.255.1651
media@komodohealth.com

Social Media Profiles
More News From Komodo Health

Komodo Health Appoints Mark Jewett to Chief Marketing Officer

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--Komodo Health, the leader in AI-powered healthcare intelligence, today announced the appointment of Mark Jewett as Chief Marketing Officer (CMO). Jewett will lead the company’s marketing, shaping brand, communications, and go-to-market strategy as it scales Marmot™ — its new AI platform designed to help Life Sciences and healthcare organizations innovate faster and serve patients better. The appointment comes following a period of significant momentum...

Komodo Health Analysis Uncovers Dual Reality in Metastatic Breast Cancer Care: Rapid Targeted Cancer Therapy Adoption Amid Glaring Age-Related Disparities

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--On the 40th anniversary of Breast Cancer Awareness Month, a new analysis from Komodo Health, the leader in AI-powered healthcare intelligence, conducted in collaboration with the Tigerlily Foundation, a national breast cancer patient advocacy organization, delivers critical insights into antibody-drug conjugate (ADC) treatment patterns in metastatic breast cancer. The study confirms growing clinical acceptance of this innovative therapy but also reveal...

Komodo Health Recognized by Forbes, TIME, and The Healthcare Technology Report for Healthcare Analytics AI Innovation

NEW YORK & SAN FRANCISCO--(BUSINESS WIRE)--Komodo Health, the leader in AI-powered healthcare intelligence, today announced that it has earned recognition on three prestigious industry lists: the 2025 Forbes Cloud 100, TIME’s inaugural World’s Top HealthTech Companies, and The Healthcare Technology Report’s Top 25 Healthcare Software Companies. These honors validate Komodo’s differentiated approach to healthcare analytics AI — purpose-built from the ground up rather than retrofitted from consum...
Back to Newsroom